BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25482158)

  • 1. Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.
    Kozan PA; McGeough MD; Peña CA; Mueller JL; Barrett KE; Marchelletta RR; Sivagnanam M
    J Mol Med (Berl); 2015 May; 93(5):535-45. PubMed ID: 25482158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of EpCam mutation in mice and men.
    Mueller JL; McGeough MD; Peña CA; Sivagnanam M
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G278-88. PubMed ID: 24337010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.
    Guerra E; Lattanzio R; La Sorda R; Dini F; Tiboni GM; Piantelli M; Alberti S
    PLoS One; 2012; 7(11):e49302. PubMed ID: 23209569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteroids expressing a disease-associated mutant of EpCAM are a model for congenital tufting enteropathy.
    Das B; Okamoto K; Rabalais J; Kozan PA; Marchelletta RR; McGeough MD; Durali N; Go M; Barrett KE; Das S; Sivagnanam M
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G580-G591. PubMed ID: 31433211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Epithelial Differentiation Contributes to Pathogenesis in a Murine Model of Congenital Tufting Enteropathy.
    Das B; Okamoto K; Rabalais J; Young JA; Barrett KE; Sivagnanam M
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1353-1371. PubMed ID: 34198013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of cell-surface EpCAM in congenital tufting enteropathy.
    Schnell U; Kuipers J; Mueller JL; Veenstra-Algra A; Sivagnanam M; Giepmans BN
    Hum Mol Genet; 2013 Jul; 22(13):2566-71. PubMed ID: 23462293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
    Salomon J; Goulet O; Canioni D; Brousse N; Lemale J; Tounian P; Coulomb A; Marinier E; Hugot JP; Ruemmele F; Dufier JL; Roche O; Bodemer C; Colomb V; Talbotec C; Lacaille F; Campeotto F; Cerf-Bensussan N; Janecke AR; Mueller T; Koletzko S; Bonnefont JP; Lyonnet S; Munnich A; Poirier F; Smahi A
    Hum Genet; 2014 Mar; 133(3):299-310. PubMed ID: 24142340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathy.
    Thoeni C; Amir A; Guo C; Zhang S; Avitzur Y; Heng YM; Cutz E; Muise AM
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):18-21. PubMed ID: 24048167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells.
    Nakato G; Morimura S; Lu M; Feng X; Wu C; Udey MC
    Cells; 2020 Aug; 9(8):. PubMed ID: 32781650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of EpCAM as the gene for congenital tufting enteropathy.
    Sivagnanam M; Mueller JL; Lee H; Chen Z; Nelson SF; Turner D; Zlotkin SH; Pencharz PB; Ngan BY; Libiger O; Schork NJ; Lavine JE; Taylor S; Newbury RO; Kolodner RD; Hoffman HM
    Gastroenterology; 2008 Aug; 135(2):429-37. PubMed ID: 18572020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins.
    Lei Z; Maeda T; Tamura A; Nakamura T; Yamazaki Y; Shiratori H; Yashiro K; Tsukita S; Hamada H
    Dev Biol; 2012 Nov; 371(2):136-45. PubMed ID: 22819673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf.
    Salomon J; Espinosa-Parrilla Y; Goulet O; Al-Qabandi W; Guigue P; Canioni D; Bruneau J; Alzahrani F; Almuhsen S; Cerf-Bensussan N; Jeanpierre M; Brousse N; Lyonnet S; Munnich A; Smahi A
    Eur J Med Genet; 2011; 54(3):319-22. PubMed ID: 21315192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital Tufting Enteropathy: Biology, Pathogenesis and Mechanisms.
    Das B; Sivagnanam M
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase.
    Ouchi T; Morimura S; Dow LE; Miyoshi H; Udey MC
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy.
    Szabo R; Callies LK; Bugge TH
    Development; 2019 Nov; 146(22):. PubMed ID: 31628112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Mutations in EPCAM Cause Congenital Tufting Enteropathy.
    Tang W; Huang T; Xu Z; Huang Y
    J Clin Gastroenterol; 2018 Jan; 52(1):e1-e6. PubMed ID: 27875355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.
    Pathak SJ; Mueller JL; Okamoto K; Das B; Hertecant J; Greenhalgh L; Cole T; Pinsk V; Yerushalmi B; Gurkan OE; Yourshaw M; Hernandez E; Oesterreicher S; Naik S; Sanderson IR; Axelsson I; Agardh D; Boland CR; Martin MG; Putnam CD; Sivagnanam M
    Hum Mutat; 2019 Feb; 40(2):142-161. PubMed ID: 30461124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Tufting Enteropathy-Associated Mutant of Epithelial Cell Adhesion Molecule Activates the Unfolded Protein Response in a Murine Model of the Disease.
    Das B; Okamoto K; Rabalais J; Marchelletta RR; Barrett KE; Das S; Niwa M; Sivagnanam M
    Cells; 2020 Apr; 9(4):. PubMed ID: 32290509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM.
    Szabo R; Kawaguchi M; Kataoka H; Bugge TH
    Development; 2023 Sep; 150(17):. PubMed ID: 37539662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.
    Gilboa-Geffen A; Hamar P; Le MT; Wheeler LA; Trifonova R; Petrocca F; Wittrup A; Lieberman J
    Mol Cancer Ther; 2015 Oct; 14(10):2279-91. PubMed ID: 26264278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.